Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Apogee’s declared proposed guaranteed public offering
13 October 2025

Apogee’s declared proposed guaranteed public offering

  Image Credit: Yahoo Finance Announcement  Apogee Therapeutics Inc., a leading clinical-level biotechnology company accelerating optimization, novel biologics with standing ability for excellent profiles in the immunology and inflammatory (I and I) sector, has declared an underwritte...

Sanofi enters the realm of radiopharma with a competition to Novartis
13 October 2025

Sanofi enters the realm of radiopharma with a competition to Novartis

Image Credit: Medcity News Announcement  Sanofi’s Orano breakthrough radioligand therapy, Alphamedix, has successfully passed the efficacy test, meeting an excellent endpoint. Involving a cumulative response rate in its mid-stage study of ALPHAMEDIX-02. On the other side, Novartis, an...

Medtronic’s vitalflow ECMO expansion in Europe
10 October 2025

Medtronic’s vitalflow ECMO expansion in Europe

Image Credit: MassDevice Announcement  Medtronic, a leading global medtech company, has expanded its VitalFlow One-System ECMO solution with the official launch in Europe. The VitalFlow extracorporeal membrane oxygenation (ECMO) system, integrated in the cardiac surgery portfolio, was a win...

Cigna introduces a new healthcare solution
10 October 2025

Cigna introduces a new healthcare solution

Announcement  Cigna Healthcare is a leading health benefits business of the Cigna Group, has introduced a new healthcare solution focusing on Japanese expatriate employees or individuals working in the UK. The product (healthcare solution platform) provides a ‘doorkeeper’ alterna...

nChroma to receive approval for abstracts at the meeting of the AASLD
10 October 2025

nChroma to receive approval for abstracts at the meeting of the AASLD

Announcement  The nChroma Bio, a leading genetic medicines company developing in vivo delivery of unique cargoes to address the limitations of the previous therapies, has received approval for its three abstracts, as well as the poster of distinction that will be officially confirmed at the ...

Huvepharma and Checkerspot entered a commercial-purpose partnership contract
10 October 2025

Huvepharma and Checkerspot entered a commercial-purpose partnership contract

Image Credit: Vegconomist Announcement  Checkerspot, a certified B corporation and a leading biotechnology company that works on renewable oils and fats via the fermentation of microalgae, and Huvepharma, a known leading fermentation and biopharmaceutical company, have entered a commercial-...

Gain’s initial data from its clinical study in parkinson’s patients presented at an event
09 October 2025

Gain’s initial data from its clinical study in parkinson’s patients presented at an event

Image Credit: Swisscore Announcement  Gain Therapeutics Inc., a leading clinical-level biotechnology company known for its development and exploratory-based next generation of allosteric small molecule therapies, has showcased the poster of parkinson’s disease and movement disorder at...

Roboeatz and Aramark’s new automation innovation for healthcare staff
09 October 2025

Roboeatz and Aramark’s new automation innovation for healthcare staff

Image Credit: AI Insider Announcement  Aramark, the leading American-based company providing its dedication in the facilities, uniform, and food services to the people through Canada and the US, along with its partner roboeatz have introduced a new technology named ‘round-the-clock&rs...

Amgen 60% discount on the cholesterol drug
09 October 2025

Amgen 60% discount on the cholesterol drug

Image Credit: Reuters Announcement  Amgen has freshly introduced its direct-to-consumer US sales of Repatha, the cholesterol-lowering medication, at a 60% discount price rate. With the discount, the company has become the recent pharmaceutical companies to respond to the US political tactic...

Biomea Fusion’s next trade move
09 October 2025

Biomea Fusion’s next trade move

Announcement  The Biomea Fusion Inc., a leading clinical-level obesity and diabetes company, announced its proposed public offering of securities. The company declared an underwritten public offering of accompanying warrants and shares of its common stock to buy shares of its common stock or...